When did Bausch + Lomb report Q1 2025 earnings?

Bausch + Lomb (BLCO) reported Q1 2025 earnings on April 30, 2025 before market open.

What were Bausch + Lomb's Q1 2025 revenue and EPS?

Bausch + Lomb reported revenue of $1.1B and eps of $-0.07 for Q1 2025.

Did Bausch + Lomb beat estimates in Q1 2025?

Revenue missed the consensus estimate of $1.3B by $120.1M. EPS missed the consensus estimate of $0.03 by $0.10.

How did Bausch + Lomb's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 3.1% from $1.1B a year earlier.

Where can I find Bausch + Lomb's Q1 2025 SEC filings?

You can read the 10-Q periodic report (0001860742-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.

Bausch + Lomb BLCO Q1 2025 earnings

Reported April 30, 2025 · Before market open

Revenue$1.1BMiss by $120.1M

EPS-$0.07Miss by $0.10

Revenue estimate$1.3B

EPS estimate$0.03

Next report

Date not yet announced

Financials

Q1 2025

Income statement

See full

Revenue$1.1B+3.5%

Operating income-$83.0M-1,483%

Net income-$212.0M-26.9%

EPS (diluted)-$0.60-25.0%

Balance sheet

See full

Cash & equivalents$215.0M-33.8%

Total debt$4.8B+5.3%

Total equity$6.4B-4.5%

Total assets$13.4B+1.0%

Cash flow

See full

Operating cash flow-$25.0M-161%

CapEx$110.0M+64.2%

Free cash flow-$135.0M-419%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$5.11B-15.8%

Enterprise value$9.72B-5.9%

P/S1.1×-0.3×

Profitability

See full

Operating margin1.5%-1.7pp

Net margin-7.5%-0.3pp

FCF margin-3.5%+0.1pp

Returns & leverage

See full

Return on equity-5.6%+0.8pp

Debt / equity0.8×+0.1×

Current ratio1.6×-0.1×

Segments

By segment

See full

Vision Care$656.0M+3.3%

Pharmaceuticals$222.0M+6.2%

Surgical$214.0M+8.6%

By product

See full

Devices$448.0M+5.7%

OTC$409.0M+3.5%

Branded and Other Generics$54.0M-18.2%

Versus estimates

Revenue

Q2 2026$1.4BBeat by $24.8M Q1 2026$1.2BBeat by $28.3M Q4 2025$1.4BBeat by $19.7M Q3 2025$1.3BMiss by $102.4M Q2 2025$1.3BBeat by $3.9M

Q1 2025$1.1BMiss by $120.1M

Diluted EPS

Q2 2026$0.16Beat by $0.01 Q1 2026$0.08Beat by $0.02 Q4 2025$0.32Miss by $0.03 Q3 2025$0.18Beat by $0.02 Q2 2025$0.07Beat by $0.01

Q1 2025-$0.07Miss by $0.10

Ask the moment Bausch + Lomb reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Bausch + Lomb report Q1 2025 earnings?: Bausch + Lomb (BLCO) reported Q1 2025 earnings on April 30, 2025 before market open.
What were Bausch + Lomb's Q1 2025 revenue and EPS?: Bausch + Lomb reported revenue of $1.1B and eps of $-0.07 for Q1 2025.
Did Bausch + Lomb beat estimates in Q1 2025?: Revenue missed the consensus estimate of $1.3B by $120.1M. EPS missed the consensus estimate of $0.03 by $0.10.
How did Bausch + Lomb's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 3.1% from $1.1B a year earlier.
Where can I find Bausch + Lomb's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001860742-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.